Endocrine surgery has undergone significant innovation in recent decades, leading to improved clinical outcomes and fewer surgical complications.

Numerous “minimally invasive” approaches are used for thyroid and parathyroid surgery (TOETVA, BABA, transaxillary, etc., with or without the robot) but, unlike other areas of surgery, “minimally” invasive surgery has yet to find its method of choice for thyroid and parathyroid surgery. However, significant improvements have been achieved with vessel sealing systems and neuromonitoring systems, making it possible to anticipate potential loss of signal and to reduce the risk of nerve complications.

Other innovative techniques are emerging, particularly optical techniques (auto-fluorescence, dye-based fluorescence, laser speckel contract imaging, etc.) to detect parathyroid glands and to demonstrate their degree of perfusion (and hence function). Optical techniques are also being developed to detect nerve structures, thyroid nodules as well as cancers.

In addition, minimally invasive tissue destruction techniques (radiofrequency, High Intensity Focus Ultrasound, laser, etc.) are increasingly used to complement surgical approaches for the destruction of hyper functional or non-functional nodules.

In this context, we are pleased to invite you to participate in "New Approaches in Endocrine Surgery: Fluorescence, Non-Surgical Ablation, and much more" March 12-14, 2025, in Barcelona, Spain. We are eager to gather people interested in this new area of research to help increase the safety of thyroid and parathyroid surgeries.

We look forward to an exciting and friendly exchange of ideas and to help move the field forward!